<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f1 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f2 { font-family:ff0,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
#f3 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
#f4 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f5 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f6 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f7 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.ttf"); }
#f8 { font-family:ff6,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.ttf"); }
#f9 { font-family:ff7,sans-serif; font-weight:normal; font-style:normal; }
#f10 { font-family:sans-serif; font-weight:bold; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="841" src="page1.png">
<div class="txt" style="position:absolute; left:412px; top:30px;"><span id="f3" style="font-size:18px;vertical-align:baseline;color:rgba(0,0,0,1);">실적 </span><span id="f10" style="font-size:14px;vertical-align:baseline;color:rgba(0,0,0,1);">Review</span></div>
<div class="txt" style="position:absolute; left:412px; top:60px;"><span id="f10" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2019. 5. 2</span></div>
<div class="txt" style="position:absolute; left:38px; top:137px;"><span id="f3" style="font-size:27px;vertical-align:baseline;color:rgba(0,0,0,1);">한미약품</span><span id="f4" style="font-size:21px;vertical-align:baseline;color:rgba(0,0,0,1);">(128940)</span></div>
<div class="txt" style="position:absolute; left:426px; top:135px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">하 회</span></div>
<div class="txt" style="position:absolute; left:474px; top:135px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">부 합</span></div>
<div class="txt" style="position:absolute; left:412px; top:153px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">영업이익의 컨센서스 대비를 의미</span></div>
<div class="txt" style="position:absolute; left:524px; top:135px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">상 회</span></div>
<div class="txt" style="position:absolute; left:38px; top:201px;"><span id="f3" style="font-size:15px;vertical-align:baseline;color:rgba(0,0,0,1);">본업의 호조로 실적도 양호</span></div>
<div class="txt" style="position:absolute; left:412px; top:202px;"><span id="f3" style="font-size:18px;vertical-align:baseline;color:rgba(0,0,0,1);">매수</span><span id="f4" style="font-size:18px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f3" style="font-size:18px;vertical-align:baseline;color:rgba(0,0,0,1);">유지</span><span id="f4" style="font-size:18px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:49px; top:245px;"><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">주력제품 판매호조로 컨센서스 상회한 영업이익</span></div>
<div class="txt" style="position:absolute; left:49px; top:263px;"><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">연구개발은 멈추지 않는다</span></div>
<div class="txt" style="position:absolute; left:49px; top:281px;"><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">파이프라인 마일스톤에 대한 지속적 관심권고</span></div>
<div class="txt" style="position:absolute; left:38px; top:324px;"><span id="f2" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">Facts : </span><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">주력제품 판매호조로 컨센서스를 상회한 영업이익</span></div>
<div class="txt" style="position:absolute; left:38px; top:342px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">고혈압 치료제 아모잘탄</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">역류성식도염 치료제 에소메졸</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">고지혈증 치료제 로수젯 등</span></div>
<div class="txt" style="position:absolute; left:38px; top:358px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">주력제품의 판매호조로 매출은 전년대비 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">12% </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">늘었으며 영업이익은 컨센서스를 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">18%</span></div>
<div class="txt" style="position:absolute; left:38px; top:374px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상회한 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">260</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(-1% YoY, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">영업이익률 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">9.5%)</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">을 기록했다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. 1</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">분기 집행된 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">R&amp;D</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">비</span></div>
<div class="txt" style="position:absolute; left:38px; top:390px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">용</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">자체임상 및 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Efpeglenatide </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">임상 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상에 대한 비용부담</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">은 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">593</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원으로 전년대</span></div>
<div class="txt" style="position:absolute; left:38px; top:406px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">비 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">26% </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">증가했으며 연결기준 매출의 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">22%</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">에 육박하는 수준이었음에도 양호한 실적</span></div>
<div class="txt" style="position:absolute; left:38px; top:422px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">을 기록했다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:38px; top:452px;"><span id="f2" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">Pros &amp; cons : </span><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">연구개발은 멈추지 않는다</span></div>
<div class="txt" style="position:absolute; left:38px; top:470px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">올해는 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">R&amp;D</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">비용이 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2,204</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원으로 전년대비 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">21% </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">늘어날 것으로 예상되기에 본업</span></div>
<div class="txt" style="position:absolute; left:38px; top:486px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 선방이 그 어느 때보다 반갑다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">하지만 올해 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">분기부터 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Genentech</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">으로부터 유</span></div>
<div class="txt" style="position:absolute; left:38px; top:502px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">입된 기술료의 매출반영이 종료된다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">따라서 올해는 이익이 크게 개선될 수 있는 상</span></div>
<div class="txt" style="position:absolute; left:38px; top:518px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">황이 아니다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">올해 영업이익은 전년대비 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">16% </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">감소한 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">703</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">영업이익률 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">7%)</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">을</span></div>
<div class="txt" style="position:absolute; left:38px; top:534px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">예상한다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">최근 한미약품은 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">BTK </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">저해제 권리반환</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">롤론티스 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">BLA </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">제출지연 등 파</span></div>
<div class="txt" style="position:absolute; left:38px; top:550px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">이프라인 마일스톤에 차질이 있었다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">하지만 올해 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">분기에는 경구용 항암신약 오락</span></div>
<div class="txt" style="position:absolute; left:38px; top:566px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">솔 임상 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상 환자모집 완료</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">포지오티닙 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상 환자모집 완료</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">차세대 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">AML</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">치료제인</span></div>
<div class="txt" style="position:absolute; left:38px; top:582px;"><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">FLT </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">저해제</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(HM43239) </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 임상 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상 개시 등 다양한 마일스톤이 있었다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">그</span></div>
<div class="txt" style="position:absolute; left:38px; top:598px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">외에도 벨라티닙</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">고형암</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">), LSD1 </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">저해제</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">소세포폐암</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, AML), A2AR </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">길항제</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">면역항</span></div>
<div class="txt" style="position:absolute; left:38px; top:614px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">암</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">) </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">등 신규 파이프라인이 지속적으로 공개되고 있어 파이프라인 가치의 점진적인</span></div>
<div class="txt" style="position:absolute; left:38px; top:630px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상승을 기대해 본다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:38px; top:660px;"><span id="f2" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">Action : </span><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">파이프라인 마일스톤에 대한 지속적 관심권고</span></div>
<div class="txt" style="position:absolute; left:38px; top:678px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">매수의견과 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SOTP</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">로 산출한 목표주가 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">53</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">만원을 유지한다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">목표 시가총액은 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">5.94</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">조</span></div>
<div class="txt" style="position:absolute; left:38px; top:694px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">원이며 본업가치 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">1.74</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">조원</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">신약가치 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">4.77</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">조원</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">순현금 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">-0.56</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">조원을 합산하여 산출</span></div>
<div class="txt" style="position:absolute; left:38px; top:710px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">했다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">현금흐름 개선이나 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">valuation</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 정당화 측면에서 이제는 기술료 유입이나 추</span></div>
<div class="txt" style="position:absolute; left:38px; top:726px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">가적인 기술수출과 같은 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">R&amp;D </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">결실이 절실하다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. 2</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">분기에는 오락솔의 임상 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상 중간</span></div>
<div class="txt" style="position:absolute; left:38px; top:742px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">결과 발표</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, HM12525A(</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">당뇨</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">/</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">비만</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">), </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">임상 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2</span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상 종료</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">롤론티스 </span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">BLA </span><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">재신청 등의 파</span></div>
<div class="txt" style="position:absolute; left:38px; top:758px;"><span id="f8" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">이프라인 마일스톤에 대한 지속적인 관심을 권고한다</span><span id="f9" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:412px; top:234px;"><span id="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">목표주가</span><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">: 530,000</span><span id="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">원</span><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">유지</span><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:412px; top:259px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Stock Data</span></div>
<div class="txt" style="position:absolute; left:412px; top:271px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">KOSPI(4/30)</span></div>
<div class="txt" style="position:absolute; left:542px; top:271px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2,204</span></div>
<div class="txt" style="position:absolute; left:412px; top:283px;"><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">주가</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(4/30)</span></div>
<div class="txt" style="position:absolute; left:536px; top:283px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">434,500</span></div>
<div class="txt" style="position:absolute; left:412px; top:294px;"><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">시가총액</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">십억원</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:542px; top:294px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">5,045</span></div>
<div class="txt" style="position:absolute; left:412px; top:305px;"><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">발행주식수</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">백만</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:551px; top:305px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">12</span></div>
<div class="txt" style="position:absolute; left:412px; top:317px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">52</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">주 최고</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">/</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">최저가</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">원</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:511px; top:317px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">505,315/372,363</span></div>
<div class="txt" style="position:absolute; left:412px; top:328px;"><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">일평균거래대금</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(6</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">개월</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">백만원</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:539px; top:328px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">16,692</span></div>
<div class="txt" style="position:absolute; left:412px; top:339px;"><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">유동주식비율</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">/</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">외국인지분율</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(%)</span></div>
<div class="txt" style="position:absolute; left:532px; top:339px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">58.0/15.0</span></div>
<div class="txt" style="position:absolute; left:412px; top:351px;"><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">주요주주</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(%) </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">한미사이언스 외 </span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">3 </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">인</span></div>
<div class="txt" style="position:absolute; left:546px; top:351px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">41.4</span></div>
<div class="txt" style="position:absolute; left:462px; top:362px;"><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">국민연금</span></div>
<div class="txt" style="position:absolute; left:546px; top:362px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">10.0</span></div>
<div class="txt" style="position:absolute; left:412px; top:384px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Valuation </span><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">지표</span></div>
<div class="txt" style="position:absolute; left:412px; top:408px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">PER(x)</span></div>
<div class="txt" style="position:absolute; left:412px; top:419px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">PBR(x)</span></div>
<div class="txt" style="position:absolute; left:412px; top:431px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ROE(%)</span></div>
<div class="txt" style="position:absolute; left:412px; top:442px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">DY(%)</span></div>
<div class="txt" style="position:absolute; left:412px; top:454px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">EV/EBITDA(x)</span></div>
<div class="txt" style="position:absolute; left:412px; top:465px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">EPS(</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">원</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:412px; top:476px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">BPS(</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">원</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:473px; top:397px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2018A</span></div>
<div class="txt" style="position:absolute; left:475px; top:408px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">215.0</span></div>
<div class="txt" style="position:absolute; left:481px; top:419px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">7.4</span></div>
<div class="txt" style="position:absolute; left:481px; top:431px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">3.5</span></div>
<div class="txt" style="position:absolute; left:481px; top:442px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0.1</span></div>
<div class="txt" style="position:absolute; left:478px; top:454px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">45.0</span></div>
<div class="txt" style="position:absolute; left:475px; top:465px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2,158</span></div>
<div class="txt" style="position:absolute; left:471px; top:476px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">62,395</span></div>
<div class="txt" style="position:absolute; left:507px; top:397px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2019F</span></div>
<div class="txt" style="position:absolute; left:508px; top:408px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">113.4</span></div>
<div class="txt" style="position:absolute; left:515px; top:419px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">7.0</span></div>
<div class="txt" style="position:absolute; left:515px; top:431px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6.3</span></div>
<div class="txt" style="position:absolute; left:515px; top:442px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0.1</span></div>
<div class="txt" style="position:absolute; left:512px; top:454px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">44.4</span></div>
<div class="txt" style="position:absolute; left:508px; top:465px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">3,833</span></div>
<div class="txt" style="position:absolute; left:505px; top:476px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">62,437</span></div>
<div class="txt" style="position:absolute; left:540px; top:397px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2020F</span></div>
<div class="txt" style="position:absolute; left:546px; top:408px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">97.0</span></div>
<div class="txt" style="position:absolute; left:549px; top:419px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6.5</span></div>
<div class="txt" style="position:absolute; left:549px; top:431px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">7.1</span></div>
<div class="txt" style="position:absolute; left:549px; top:442px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0.1</span></div>
<div class="txt" style="position:absolute; left:546px; top:454px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">39.7</span></div>
<div class="txt" style="position:absolute; left:542px; top:465px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">4,479</span></div>
<div class="txt" style="position:absolute; left:539px; top:476px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">66,863</span></div>
<div class="txt" style="position:absolute; left:412px; top:498px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">주가상승률</span></div>
<div class="txt" style="position:absolute; left:412px; top:522px;"><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">절대주가</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(%)</span></div>
<div class="txt" style="position:absolute; left:412px; top:533px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">KOSPI </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">대비</span><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(%p)</span></div>
<div class="txt" style="position:absolute; left:485px; top:511px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">개월</span></div>
<div class="txt" style="position:absolute; left:487px; top:522px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(4.7)</span></div>
<div class="txt" style="position:absolute; left:487px; top:533px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(7.7)</span></div>
<div class="txt" style="position:absolute; left:514px; top:511px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">개월</span></div>
<div class="txt" style="position:absolute; left:517px; top:522px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">16.7</span></div>
<div class="txt" style="position:absolute; left:520px; top:533px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">7.3</span></div>
<div class="txt" style="position:absolute; left:539px; top:511px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">12</span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">개월</span></div>
<div class="txt" style="position:absolute; left:544px; top:522px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(5.0)</span></div>
<div class="txt" style="position:absolute; left:549px; top:533px;"><span id="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">7.4</span></div>
<div class="txt" style="position:absolute; left:412px; top:555px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">주가추이</span></div>
<div class="txt" style="position:absolute; left:429px; top:573px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">천원</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:413px; top:578px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">700</span></div>
<div class="txt" style="position:absolute; left:413px; top:593px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">600</span></div>
<div class="txt" style="position:absolute; left:413px; top:608px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">500</span></div>
<div class="txt" style="position:absolute; left:413px; top:623px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">400</span></div>
<div class="txt" style="position:absolute; left:413px; top:638px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">300</span></div>
<div class="txt" style="position:absolute; left:413px; top:653px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">200</span></div>
<div class="txt" style="position:absolute; left:421px; top:660px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Apr-17</span></div>
<div class="txt" style="position:absolute; left:412px; top:674px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: FnGuide</span></div>
<div class="txt" style="position:absolute; left:472px; top:660px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Apr-18</span></div>
<div class="txt" style="position:absolute; left:523px; top:660px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Apr-19</span></div>
<div class="txt" style="position:absolute; left:412px; top:753px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">hg.jin@truefriend.com</span></div>
</body>
</html>
